Clenbuterol for ALS: Findings from an Open Label Trial

Register to upcoming events
everythingals.org/events
Participate in our ALS Research
everythingals.org/research
Clenbuterol for ALS, Findings from an Open Label Trial with Dr. Richard Bedlack from Duke University.
Richard Bedlack M.D., Ph.D. is currently a Professor of Neurology at Duke University, and Director of the Duke ALS Clinic. He has won awards for teaching and for patient care, including: best neurology teacher at Duke; Health Care Hero; Strength, Hope, and Caring Award; America’s Best Doctors; the American Academy of Neurology's Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award, and the ALS Association's Rasmussen Award for ALS Patient Advocate of the Year.
Dr. Bedkack has also received research grants, participated in clinical trials, and published more than 130 articles. He currently leads the international ALSUntangled program, which utilizes social networking to investigate alternative and off-label treatment options for patients with ALS, and the ALS Reversals program which seeks to verify and understand cases of recovery from ALS in hopes of making them happen more often.
DO NOT Miss Another Event, Subscribe to our Channel:
/ everythingals